Last reviewed · How we verify
tDCS
At a glance
| Generic name | tDCS |
|---|---|
| Sponsor | Tel-Aviv Sourasky Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION ON NAMING IN APHASIC PATIENTS WITH ACUTE ISCHEMIC STROKE (PHASE3)
- Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Integrated Treatment for Pain and PTSD (NA)
- Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study (NA)
- Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System (EARLY_PHASE1)
- Enhancing Slow Wave Sleep in Depression (NA)
- Treating Traumatic Brain Injury With Transcranial Direct Current Stimulation (NA)
- Temporal Pole Transcranial Alternating Current Stimulation for Children With Autism Spectrum Disorder (NA)
- Combined Non-Invasive Brain and Visual Stimulation for Vision Improvement (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- tDCS CI brief — competitive landscape report
- tDCS updates RSS · CI watch RSS
- Tel-Aviv Sourasky Medical Center portfolio CI